Edition:
United States

AngioDynamics Inc (ANGO.O)

ANGO.O on Nasdaq

17.95USD
18 Sep 2017
Change (% chg)

-- (--)
Prev Close
$17.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
206,628
52-wk High
$18.35
52-wk Low
$14.80

Latest Key Developments (Source: Significant Developments)

AngioDynamics reports Q4 loss per share $0.30
Tuesday, 18 Jul 2017 06:00am EDT 

July 18 (Reuters) - Angiodynamics Inc :Reports FY 2017 GAAP EPS of $0.19; adjusted EPS of $0.73, up 22% compared to FY2016​.Angiodynamics reports fiscal 2017 fourth quarter and full-year results.Q4 adjusted non-gaap earnings per share $0.19 excluding items.Q4 loss per share $0.30.Q4 sales $86.9 million versus i/b/e/s view $90.7 million.Q4 earnings per share view $0.16 -- Thomson Reuters I/B/E/S.Angiodynamics inc says issued its fy2018 financial guidance affirming a net sales range of $352 to $359 million.Sees fy 2018 adjusted earnings per share $0.64 to $0.68.Fy2018 earnings per share view $0.68, revenue view $357.3 million -- Thomson Reuters I/B/E/S.  Full Article

AngioDynamics lawsuit claims C.R. Bard is violating antitrust laws, harming competition, limiting access
Wednesday, 31 May 2017 06:00am EDT 

May 31 (Reuters) - AngioDynamics Inc ::AngioDynamics - "C.R. Bard has illegally tied sale of tip location systems to line of peripherally inserted central catheters," as per lawsuit filed by co.AngioDynamics - lawsuit claims that C.R. Bard will only sell proprietary stylet necessary to operate its tip location systems preloaded in its PICCs.  Full Article

Angiodynamics reports Q3 earnings per share $0.08
Thursday, 30 Mar 2017 06:00am EDT 

Angiodynamics Inc : Angiodynamics reports fiscal 2017 third quarter results . Q3 earnings per share $0.08 . Q3 sales $85.6 million versus I/B/E/S view $88.3 million . Q3 earnings per share view $0.15 -- Thomson Reuters I/B/E/S . Raises fy 2017 adjusted earnings per share view to $0.68 to $0.70 . Sees FY 2017 revenue $352 million to $355 million . Q3 adjusted non-GAAP earnings per share $0.19 excluding items . FY2017 earnings per share view $0.67, revenue view $358.7 million -- Thomson Reuters I/B/E/S .Angiodynamics Inc - revising its FY2017 revenue guidance from a range of $355 million to $360 million to a range of $352 million to $355 million.  Full Article

AngioDynamics reports fiscal 2017 first quarter results
Wednesday, 5 Oct 2016 06:00am EDT 

AngioDynamics Inc : AngioDynamics reports fiscal 2017 first quarter results . Q1 adjusted non-GAAP earnings per share $0.17 . Q1 sales $88.1 million versus I/B/E/S view $86 million . Q1 earnings per share $0.04 . Q1 earnings per share view $0.13 -- Thomson Reuters I/B/E/S . Sees FY 2017 adjusted earnings per share $0.62 to $0.65 . FY2017 guidance remains unchanged . FY2017 earnings per share view $0.63, revenue view $358.6 million -- Thomson Reuters I/B/E/S .Sees FY 2017 sales $355 million to $360 million.  Full Article

AngioDynamics names Michael Greiner as new CFO
Monday, 25 Jul 2016 07:35am EDT 

AngioDynamics Inc : AngioDynamics appoints Michael C. Greiner as new chief financial officer .Greiner most recently served as chief financial officer at extreme reach.  Full Article

Intouch Health appoints Joseph Devivo as new CEO
Tuesday, 19 Jul 2016 08:30am EDT 

Intouch Health: Says Intouch Health announces new CEO . Intouch Health says appointed Joseph M. Devivo as its new chief executive officer .Says Devivo was most recently President, CEO and Director Of AngioDynamics.  Full Article

Angiodynamics reports Q4 loss $1.21/shr
Wednesday, 13 Jul 2016 06:00am EDT 

Angiodynamics Inc : Angiodynamics reports fiscal 2016 fourth quarter and full year results . Sees Q1 adjusted shr $0.11 to $0.14 . Q4 shr loss $1.21 . Sees Q1 sales $84 mln to $87 mln . Q4 sales $93.4 mln vs I/B/E/S view $88.4 mln . Q4 shr view $0.16 -- thomson reuters I/B/E/S . Sees FY 2017 adjusted shr $0.62 to $0.65 . Q4 adjusted non-GAAP shr $0.19 excluding items . Sees FY 2017 sales $355 mln to $360 mln . Sees FY2017 free cash flow guidance of greater than $30 mln . FY2017 shr view $0.66, rev view $358.6 mln -- Thomson Reuters I/B/E/S .Q1 shr view $0.14, rev view $86.4 mln -- Thomson Reuters I/B/E/S.  Full Article

AngioDynamics Inc lowers FY 2016 guidance; gives Q3 2016 guidance below analysts' estimates
Thursday, 7 Jan 2016 04:01pm EST 

AngioDynamics Inc:Revised FY 2016 net sales guidance to $353 to $359 million and adjusted earnings per share (EPS) of $0.59 to $0.63.expects Q3 2016 net sales to be in the range of $84 to $87 million and adjusted EPS of $0.10 to $0.14.Q3 2016 revenue of $92 million and EPS of $0.17 - Thomson Reuters I/B/E/S.FY 2016 revenue of $363 million and EPS of $0.62 - Thomson Reuters I/B/E/S.  Full Article

AngioDynamics Inc says CFO Mark Frost resigned
Monday, 9 Nov 2015 08:30am EST 

AngioDynamics Inc:Announces resignation of CFO and appointment of interim CFO.Says CFO Mark Frost Resigned.Michael trimarchi will serve as interim CFO.  Full Article

AngioDynamics Inc announces the approval of the NanoKnife System in South Korea
Thursday, 15 Oct 2015 07:00am EDT 

AngioDynamics Inc:Announces the Approval of the NanoKnife System in South Korea.Says has already begun selling the Nanoknife System to healthcare providers in South Korea through exclusive distribution partnerships.  Full Article

BRIEF-AngioDynamics reports Q4 loss per share $0.30

* Reports FY 2017 GAAP EPS of $0.19; adjusted EPS of $0.73, up 22% compared to FY2016​